Chengdu Jouav Automation Tech Co., Ltd. (688070.SH) has forecasted a pre-loss and expects a net loss of approximately 33.65 million yuan in the fiscal year 2024.
Zongheng Holdings (688070.SH) issued an announcement, the company expects to achieve attributable to the shareholders of the listed company in 2024...
Chengdu Jouav Automation Tech Co., Ltd. (688070.SH) announced that the company expects to achieve a net loss of approximately 33.65 million yuan attributable to the shareholders of the listed company in 2024, a decrease of approximately 30.85 million yuan compared to the same period last year.
To maintain market competitiveness and prepare for strategic markets in advance, the company continues to increase its investment in research and development of new products such as the Cloud Dragon heavy-duty unmanned aerial vehicle and unmanned surveillance systems. Research and development expenses have increased year-on-year, and the depreciation of fixed assets has increased significantly after the use of the company's raised funds investment projects, leading to an increase in operating expenses such as management expenses. Due to the above factors, the company's net profit continues to be in a loss.
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025